350 Odcinki

  1. Episode 29: A Hong Kong heat-check, a $20 million wrist slap, and pharma's (other) diversity problem

    Opublikowany: 20.09.2018
  2. Episode 28: Founders' funds, doctors' disclosures, and the subtle art of beeping

    Opublikowany: 13.09.2018
  3. Episode 27: Live from Boston!

    Opublikowany: 6.09.2018
  4. Episode 26: FDA shows its teeth, biotech fish oil might be pointless, & treating McCain's cancer

    Opublikowany: 30.08.2018
  5. Episode 25: A genome-editing first, Trump on Wall Street, and biotech red flags

    Opublikowany: 23.08.2018
  6. Episode 24: A lesson in startup jargon, pharma's bare Alzheimer's cupboard, and the cost of CAR-T

    Opublikowany: 16.08.2018
  7. Episode 23: Congressional insider trading, PETA and fake meat, & doctors vs. fund managers

    Opublikowany: 9.08.2018
  8. Episode 22: Biotech's battle for talent, Sanofi's second act, and climbing Mt. Everest

    Opublikowany: 2.08.2018
  9. Episode 21 - A debatable Alzheimer's breakthrough, Gilead's golden age, and "robust" data

    Opublikowany: 26.07.2018
  10. Episode 20 - CRISPR freakouts, drug prices meet elections, and a busy earnings season

    Opublikowany: 19.07.2018
  11. Episode 19: Trump's telephonic prowess, Biogen's mysterious future, & the rise of 'hypelines'

    Opublikowany: 12.07.2018
  12. Episode 18: Biotech's six-month review, how to become a day trader and soul-searching analysts

    Opublikowany: 5.07.2018
  13. Episode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China

    Opublikowany: 28.06.2018
  14. Episode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype

    Opublikowany: 21.06.2018
  15. Episode 15: Problematic parties, Nitpicking NASH, and an opioid documentary from STAT

    Opublikowany: 14.06.2018
  16. Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO

    Opublikowany: 7.06.2018
  17. Episode 13: Spending millions on fatty liver disease. Overhyped cancer drugs. Who goes to BIO?

    Opublikowany: 31.05.2018
  18. Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen

    Opublikowany: 24.05.2018
  19. Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes

    Opublikowany: 17.05.2018
  20. Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office?

    Opublikowany: 10.05.2018

17 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site